[{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 78, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.1, "open": 5.0, "dayLow": 4.91, "dayHigh": 5.27, "regularMarketPreviousClose": 5.1, "regularMarketOpen": 5.0, "regularMarketDayLow": 4.91, "regularMarketDayHigh": 5.27, "payoutRatio": 0.0, "beta": -1.292, "forwardPE": -3.2387097, "volume": 121919, "regularMarketVolume": 121919, "averageVolume": 577622, "averageVolume10days": 91100, "averageDailyVolume10Day": 91100, "bid": 5.0, "ask": 5.34, "bidSize": 1, "askSize": 1, "marketCap": 10448241, "fiftyTwoWeekLow": 3.8, "fiftyTwoWeekHigh": 38.0, "allTimeHigh": 176.4, "allTimeLow": 3.8, "fiftyDayAverage": 5.19766, "twoHundredDayAverage": 8.45519, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1891442, "profitMargins": 0.0, "floatShares": 1301227, "sharesOutstanding": 2081323, "sharesShort": 116032, "sharesShortPriorMonth": 25822, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0557, "heldPercentInsiders": 0.081149995, "heldPercentInstitutions": 0.13661, "shortRatio": 0.08, "shortPercentOfFloat": 0.0561, "impliedSharesOutstanding": 2081323, "bookValue": 2.425, "priceToBook": 2.0701032, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -9998860, "trailingEps": -10.57, "forwardEps": -1.55, "lastSplitFactor": "1:20", "lastSplitDate": 1754352000, "52WeekChange": -0.86432433, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 5.02, "targetHighPrice": 165.8, "targetLowPrice": 20.0, "targetMeanPrice": 61.7, "targetMedianPrice": 30.5, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 6064128, "totalCashPerShare": 3.826, "totalDebt": 0, "quickRatio": 2.355, "currentRatio": 2.376, "returnOnAssets": -0.98585, "returnOnEquity": -2.85935, "freeCashflow": -4532716, "operatingCashflow": -8162290, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Acurx Pharmaceuticals, Inc.", "longName": "Acurx Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "postMarketChangePercent": -0.59761375, "postMarketPrice": 4.99, "postMarketChange": -0.03000021, "regularMarketChange": -0.0799999, "regularMarketDayRange": "4.91 - 5.27", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 577622, "fiftyTwoWeekLowChange": 1.22, "fiftyTwoWeekLowChangePercent": 0.32105264, "fiftyTwoWeekRange": "3.8 - 38.0", "fiftyTwoWeekHighChange": -32.98, "fiftyTwoWeekHighChangePercent": -0.8678947, "fiftyTwoWeekChangePercent": -86.432434, "earningsTimestamp": 1762950600, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -10.57, "epsForward": -1.55, "epsCurrentYear": -6.545, "priceEpsCurrentYear": -0.7669977, "fiftyDayAverageChange": -0.17765999, "fiftyDayAverageChangePercent": -0.034180764, "twoHundredDayAverageChange": -3.4351897, "twoHundredDayAverageChangePercent": -0.4062818, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "prevName": "Acurx Pharmaceuticals, LLC", "nameChangeDate": "2025-10-31", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1761952411, "regularMarketTime": 1761940801, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.56863, "regularMarketPrice": 5.02, "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]